OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 129 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $39,000 | -65.8% | 69,991 | +5.2% | 0.00% | – |
| Q4 2015 | $114,000 | -18.6% | 66,553 | 0.0% | 0.00% | -100.0% |
| Q3 2015 | $140,000 | -57.4% | 66,553 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $329,000 | -53.3% | 66,553 | -25.9% | 0.00% | -66.7% |
| Q1 2015 | $704,000 | +24.8% | 89,870 | -3.5% | 0.00% | +50.0% |
| Q4 2014 | $564,000 | +2.4% | 93,127 | -28.0% | 0.00% | 0.0% |
| Q3 2014 | $551,000 | -28.3% | 129,293 | +4.0% | 0.00% | -33.3% |
| Q2 2014 | $768,000 | +1.5% | 124,278 | +6.7% | 0.00% | 0.0% |
| Q1 2014 | $757,000 | +36.9% | 116,514 | +18.6% | 0.00% | +50.0% |
| Q4 2013 | $553,000 | +19.4% | 98,203 | +30.2% | 0.00% | 0.0% |
| Q3 2013 | $463,000 | -23.8% | 75,433 | -27.4% | 0.00% | -33.3% |
| Q2 2013 | $608,000 | – | 103,943 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 525,000 | $2,956,000 | 1.06% |
| First Light Asset Management, LLC | 170,804 | $962,000 | 0.82% |
| PFM Health Sciences, LP | 5,047,119 | $28,415,000 | 0.57% |
| Rhenman & Partners Asset Management AB | 250,000 | $1,408,000 | 0.55% |
| NEA Management Company, LLC | 1,935,300 | $10,896,000 | 0.53% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 544,779 | $3,067,000 | 0.43% |
| APEX CAPITAL, LLC | 1,000,000 | $5,630,000 | 0.37% |
| Partner Investment Management, L.P. | 240,221 | $1,352,000 | 0.31% |
| Hudson Bay Capital Management LP | 1,002,405 | $5,644,000 | 0.23% |
| BAILARD, INC. | 243,300 | $1,370,000 | 0.22% |